Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT05788094
Eligibility Criteria:
Inclusion Criteria:
* Patients with P. vivax mono-infection as diagnosed by Rapid Diagnostic Test
* Fever or history of fever in the previous 7 days
* Quantitative G6PD activity ≥70% of the population median i.e., ≥6.1U/gHb
* Age \> 18 years, Weight \>35 kg
* Ability to understand the study instructions and provide informed consent
* Willing to be followed for 4 months and likely to adhere to the study protocol.
Exclusion Criteria:
* Coincident P. falciparum malaria or other infections
* Pregnancy
* Lactation
* Hb \< 8 g/dL
* Quantitative G6PD activity \<70% of the population median i.e., \<6.1U/gHb
* Severe malaria (as per WHO guideline)
* History of allergic or haemolytic response to any of the study drugs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05788094
Study Brief:
Protocol Section:
NCT05788094